NewsRx

Search our medical news database

Advaxis, Inc.

Advaxis Chief Science Officer to Present Benefits of Using Live Listeria as a Vaccine

Published in Oncology Business Week, November 1st, 2009

Dr. John Rothman, Executive VP of Science and Operations of Advaxis, Inc., (OTCBB: ADXS), the live, attenuated Listeria monocytogenes (Lm) biotechnology company, has been invited to present at GTCbio's Fifth Annual Modern Drug Discovery & Development Summit in San Diego, CA on Friday, October 16, 2009.

Company representatives and speakers at the conference include executives from F. Hoffmann-La Roche Ltd., (OTCQX: RHHBY.PK), Johnson & Johnson Pharmaceuticals (NYSE: JNJ), Allergan (NYSE: AGN), and GlaxoSmithKline (LSE: GSK | NYSE: GSK).

Dr. Rothman will address the translational medicine section on the topic of "The Clinical Use of Live Listeria...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Oncology Business Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook